Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7 M Yada, S Hatakeyama, T Kamura, M Nishiyama, R Tsunematsu, H Imaki, ... The EMBO journal 23 (10), 2116-2125, 2004 | 908 | 2004 |
U box proteins as a new family of ubiquitin-protein ligases S Hatakeyama, M Yada, M Matsumoto, N Ishida, KI Nakayama Journal of Biological Chemistry 276 (35), 33111-33120, 2001 | 736 | 2001 |
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease M Kohjima, M Enjoji, N Higuchi, M Kato, K Kotoh, T Yoshimoto, T Fujino, ... International journal of molecular medicine 20 (3), 351-358, 2007 | 560 | 2007 |
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease M Kohjima, N Higuchi, M Kato, K Kotoh, T Yoshimoto, T Fujino, M Yada, ... International journal of molecular medicine 21 (4), 507-511, 2008 | 447 | 2008 |
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2 S Kamizono, T Hanada, H Yasukawa, S Minoguchi, R Kato, M Minoguchi, ... Journal of biological chemistry 276 (16), 12530-12538, 2001 | 400 | 2001 |
Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation T Kamura, T Hara, S Kotoshiba, M Yada, N Ishida, H Imaki, S Hatakeyama, ... Proceedings of the National Academy of Sciences 100 (18), 10231-10236, 2003 | 361 | 2003 |
Molecular clearance of ataxin‐3 is regulated by a mammalian E4 M Matsumoto, M Yada, S Hatakeyama, H Ishimoto, T Tanimura, S Tsuji, ... The EMBO journal 23 (3), 659-669, 2004 | 199 | 2004 |
Interaction of U‐box‐type ubiquitin‐protein ligases (E3s) with molecular chaperones S Hatakeyama, M Matsumoto, M Yada, KI Nakayama Genes to Cells 9 (6), 533-548, 2004 | 104 | 2004 |
Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease M Nakamuta, T Fujino, R Yada, M Yada, K Yasutake, T Yoshimoto, ... International journal of molecular medicine 23 (5), 603-608, 2009 | 103 | 2009 |
Multiple Skp1-related proteins in Caenorhabditis elegans: diverse patterns of interaction with Cullins and F-box proteins A Yamanaka, M Yada, H Imaki, M Koga, Y Ohshima, KI Nakayama Current biology 12 (4), 267-275, 2002 | 94 | 2002 |
Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin‐dependent degradation Y Fujii, M Yada, M Nishiyama, T Kamura, H Takahashi, R Tsunematsu, ... Cancer science 97 (8), 729-736, 2006 | 86 | 2006 |
Preferential interaction of TIP120A with Cul1 that is not modified by NEDD8 and not associated with Skp1 K Oshikawa, M Matsumoto, M Yada, T Kamura, S Hatakeyama, ... Biochemical and biophysical research communications 303 (4), 1209-1216, 2003 | 80 | 2003 |
Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a C Kaneko, S Hatakeyama, M Matsumoto, M Yada, K Nakayama, ... Biochemical and biophysical research communications 300 (2), 297-304, 2003 | 74 | 2003 |
Mammalian E4 is required for cardiac development and maintenance of the nervous system C Kaneko-Oshikawa, T Nakagawa, M Yamada, H Yoshikawa, ... Molecular and Cellular Biology 25 (24), 10953-10964, 2005 | 70 | 2005 |
The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease M Nakamuta, M Kohjima, N Higuchi, M Kato, K Kotoh, T Yoshimoto, ... International journal of molecular medicine 22 (5), 663-667, 2008 | 61 | 2008 |
Expression profile of lipid metabolism‐associated genes in hepatitis C virus‐infected human liver T Fujino, M Nakamuta, R Yada, Y Aoyagi, K Yasutake, M Kohjima, ... Hepatology Research 40 (9), 923-929, 2010 | 52 | 2010 |
Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy? M Nakamuta, R Yada, T Fujino, M Yada, N Higuchi, M Tanaka, ... International journal of molecular medicine 24 (6), 825-828, 2009 | 51 | 2009 |
Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma M Yada, A Masumoto, K Motomura, H Tajiri, Y Morita, H Suzuki, T Senju, ... World Journal of Gastroenterology: WJG 20 (35), 12581, 2014 | 42 | 2014 |
Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway. M Nakamuta, T Fujino, R Yada, K Yasutake, T Yoshimoto, N Harada, ... International journal of clinical pharmacology and therapeutics 48 (1), 22-28, 2010 | 32 | 2010 |
Expression profiles of genes associated with viral entry in HCV‐infected human liver M Nakamuta, T Fujino, R Yada, Y Aoyagi, K Yasutake, M Kohjima, ... Journal of medical virology 83 (5), 921-927, 2011 | 25 | 2011 |